The effect of peripheral vascular disease on the serum levels of natural anti-oxidants: Bilirubin and albumin

International Angiology

Volumn 21, Issue 1, 2002, Pages 44-52

  Krijgsman, B ^a   Papadakis, J A ^a   Ganotakis, E S ^a   Mikhailidis, D P ^a   Hamilton, G ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Albumins, blood; Bilirubin, blood; Myocardial ischemia, etiology; Peripheral vascular diseases, etioloy; Risk factors

Indexed keywords

ANTIOXIDANT; BILIRUBIN; SERUM ALBUMIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; BILIRUBIN BLOOD LEVEL; CARDIOVASCULAR DISEASE; CLINICAL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FREQUENCY ANALYSIS; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PERIPHERAL VASCULAR DISEASE; RISK FACTOR; SEX DIFFERENCE; SMOKING; VASCULAR DISEASE;

AGE FACTORS; AGED; ANTIOXIDANTS; BILIRUBIN; BODY WEIGHT; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; HYPERLIPIDEMIAS; LONDON; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PERIPHERAL VASCULAR DISEASES; PREVALENCE; RETROSPECTIVE STUDIES; SERUM ALBUMIN; SEX FACTORS; SMOKING; STATISTICS; TRIGLYCERIDES;

EID: 0036228452     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Blood vessels
2. Free radicals, antioxidants, and human disease: Curiosity, cause, or consequence?
3. Extent of oxidative modification of low density lipoprotein determines the degree of cytotoxicity to human coronary artery cells
4. A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study
5. Cardioprotection and antihypertensive therapy: The key importance of addressing the associated coronary risk factors (the Framingham experience)
6. Blood pressure and mortality among men with prior myocardial infarction
7. New and classical risk factors - The Munster heart study (PROCAM)
8. Fibrinogen is a predictor of mortality in coronary heart disease patients
9. Fibrinogen as a cardiovascular risk factor
10. Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature
11. Association of low serum concentration of bilirubin with increased risk of coronary artery disease
12. Serum bilirubin and risk of ischemic heart disease in middle-aged British men
13. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease
14. Serum bilirubin and cardiovascular risk factors in a Chinese population
15. Role of bilirubin as an antioxidant in an ischemia-reperfusion of rat liver and induction of heme oxygenase
16. Inhibition of metal-catalyzed oxidation of low-density lipoprotein by free and albumin-bound bilirubin
17. Free and albumin-bound bilirubin are efficient co-antioxidants for α-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation
18. Is bilirubin protective against coronary artery disease?
19. Bilirubin and peripheral vascular disease
20. The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial
21. Plasma albumin and platelet function: Relevance to atherogenesis and thrombosis
22. High serum α-tocopherol, albumin, selenium and cholesterol, and low mortality from coronary heart disease in northern Finland
23. Serum albumin level as a predictor of incident coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study
24. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes
25. Serum calcium, phosphorus and albumin levels in relation to the angiographic severity of coronary artery disease
26. Racial differences in serum total bilirubin levels in health and in disease (pernicious anemia)
27. Reference distributions for the negative acute-phase proteins, albumin, transferrin, and transthyretin: A comparison of a large cohort to the world's literature
28. Targeting subclinical atherosclerosis. Has the potential to reduce coronary events dramatically
29. Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults
30. Sex- and race-related differences in liver-associated serum chemistry tests in young adults in the CARDIA study
31. Verification of smoking history in patients after infarction using urinary nicotine and cotinine measurements
32. Influence of smoking and plasma factors on patency of femoropopliteal vein grafts
33. Clinical chemistry and haematology: Adult reference values
34. Cigarette smoking and cardiovascular disease
35. Modulation of oxidant stress in vivo in chronic cigarette smokers
36. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers
37. Relationship between smoking and antioxidant nutrient status
38. Vitamins E, C and lipid peroxidation in plasma and arterial tissue of smokers and non-smokers
39. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
40. Lack of effect of long-term supplementation with β-carotene on the incidence of malignant neoplasms and cardiovascular disease
41. Gilbert's syndrome
42. Genetic variation in bilirubin UPD-glucuronosyl-transferase gene promoter and Gilbert's syndrome
43. Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome
44. Secondary prevention and referral of elderly patients to a cardiovascular lipid service
45. Effects of tobacco smoking on caloric intake
46. Natural anti-oxidants albumin and bilirubin, smoking and peripheral vascular disease
47. Bilirubin and peripheral vascular disease
48. Association of bilirubin concentration with risk of coronary artery disease